A Study on Understanding and to Assess the Prevalence of Haematological Abnormalities in Decompensated Chronic Liver Disease Patients at Tertiary Care Hospital
International Journal of Current Pharmaceutical Review and Research · 31.05.2026 · 18 (05)
DOI: 10.25258/ijcpr.18.5.69 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.05.2026. Verfasst von Dandupati Prasanthi und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Liver, one of the major organs of body which has numerous and vital roles in maintaining homeostasis. It has major role in metabolism. Liver is the largest internal organ in the body and performs functions like detoxification, production of bile for digestion, synthesize proteins, stores energy, regulates clotting. Objective: to study, understand and to assess the prevalence of haematological abnormalities in DCLD patients at Tertiary Care Hospital.
Methods
The present study was conducted at a tertiary care hospital in Visakhapatnam, Andhra Pradesh, from October to December 2025.A total of 50 patients including both sexes with decompensated chronic liver disease were included in the study.
Result
The most common etiological factors identified were chronic alcohol intake, viral hepatitis (Hepatitis B and C), non-alcoholic fatty liver disease, and other less common causes such as Wilson’s disease and α1antitrypsin deficiency. Haematological analysis revealed that anaemia was highly prevalent among DCLD patients, with 34% showing severe anaemia (Hb < 8 g/dL) and 30% having moderate anaemia. Thrombocytopenia was detected in 17 patients (34%), likely due to splenic sequestration, decreased thrombopoietin synthesis, and bone marrow suppression. Prolonged prothrombin time (PT > 13.5 sec) was seen in 60% of patients, and elevated INR in 54%, reflecting significant hepatic synthetic dysfunction and increased bleeding tendency. Leucocyte abnormalities were less frequent, with leukocytosis present in 20% of patients— primarily due to secondary infections—and leukopenia in 4%.
Conclusion
In conclusion, understanding the haematological profile of DCLD patients provide valuable insights into disease severity, guides therapeutic decisions, and ultimately helps enhance patient survival and quality of life.
Zitieren
APA
Prasanthi, D., Pappala, S. R., & Rayana, R. (2026). A Study on Understanding and to Assess the Prevalence of Haematological Abnormalities in Decompensated Chronic Liver Disease Patients at Tertiary Care Hospital. International Journal of Current Pharmaceutical Review and Research, 18(05). https://doi.org/10.25258/ijcpr.18.5.69
Vancouver
Prasanthi D, Pappala SR, Rayana R. A Study on Understanding and to Assess the Prevalence of Haematological Abnormalities in Decompensated Chronic Liver Disease Patients at Tertiary Care Hospital. International Journal of Current Pharmaceutical Review and Research. 2026;18(05). doi:10.25258/ijcpr.18.5.69
BibTeX
@article{Prasanthi2026,
author = {Prasanthi, Dandupati and Pappala, Satya Raju and Rayana, Renuka},
title = {A Study on Understanding and to Assess the Prevalence of Haematological Abnormalities in Decompensated Chronic Liver Disease Patients at Tertiary Care Hospital},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {05},
doi = {10.25258/ijcpr.18.5.69}
}
EUVIMED